Our work identifies a tumor cell-specific enhancement of pro-metastatic FABP7 and elucidates a previously unidentified mechanism for Wnt/β-catenin signaling deregulation in NSCLC. The gene discussed is FABP7; the disease is non-small cell lung carcinoma.